Ajit Puri, MD
Neuroradiology · Worcester, MANPI 1689833105
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $261,335 of the $422,064 with a category attached, or 61.9%. 19 manufacturers reported payments, led by Stryker at 32.1% of the total. Among neuroradiology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 330 payments — averaging $1278.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$135K
- Medical Device Business Services, Inc.$91K
- Microvention, Inc.$86K
- Medtronic$31K
- Route 92 Medical, Inc.$20K
- Agile Devices, Inc.$19K
- plus $40K from 13 others
Across 62 payments — averaging $7032.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$139K
- Route 92 Medical, Inc.$128K
- Medical Device Business Services, Inc.$123K
- MIVI Neuroscience, Inc.$19K
- Medtronic$15K
- Philips North America LLC$13K
Across 11 payments — averaging $15,452 each. An ownership or investment interest held by the physician or an immediate family member.
- Perfuze Limited$127K
- Agile Devices, Inc.$43K
What the payments were for
- Consulting fees$261,33562%
- Speaking & faculty fees$80,11319%
- Travel & lodging$72,32417%
- Food & beverage$8,2922%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 114 | $135,374 |
| Medical Device Business Services, Inc. | 67 | $90,729 |
| Microvention, Inc. | 62 | $86,211 |
| Medtronic(2 entities) | 36 | $30,966 |
| Route 92 Medical, Inc. | 10 | $19,998 |
| Agile Devices, Inc. | 5 | $19,200 |
| Merit Medical Systems Inc | 9 | $16,645 |
| Imperative Care, Inc | 5 | $5,329 |
| Perfuze Limited | 1 | $5,000 |
| Siemens Medical Solutions USA, Inc. | 5 | $4,473 |
| Balt USA, LLC | 3 | $3,641 |
| Depuy Synthes Products, Inc. | 2 | $3,000 |
| Vertex | 1 | $850 |
| Johnson & Johnson | 4 | $171 |
| Biosense Webster, Inc. | 2 | $149 |
| Phenox Inc. | 1 | $145 |
| Cardiva Medical, Inc. | 1 | $83 |
| Penumbra, Inc. | 1 | $65 |
| AstraZeneca | 1 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SURPASS$71,788
- WEB Aneurysm Embolization System$55,557
- EMBOGUARD$45,245
- TREVO$33,773
- Pipeline$29,895
- SURPASS EVOLVE$22,349
- TRUFILL$20,703
- STENT$20,644
- 8F Base Camp Sheath System$19,716
- NeuroNav$19,200
- SYNCHRO SELECT$15,750
- WEB$14,309
- PULSERIDER$13,852
- SPOTLIGHT$9,750
- ZOOM RDL RADIAL ACCESS SYSTEM, 103CM$4,000
- FLOWGATE$2,800
- Access$1,800
- Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device$1,800
- EVOLVE$1,700
- Prelude Introducers$1,550
How this compares
$422,064 in reported general payments places this provider in the 90th percentile of 35 neuroradiology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 30 | $14,807 |
| ClopidogrelClopidogrel Bisulfate | 49 | $403 |
| Pantoprazole Sodium | 35 | $299 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta | $35 | $14,80730 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 35 neuroradiology providers in Massachusetts.
Other neuroradiology in Worcester
- Mark MasciocchiWorcester$18K
- Jasmeet SinghWorcester$669
- Ganesh JoshiWorcester$87
- Alma SorensenBoston$974K
- Joshua HirschBoston$651K
- Jonathan KleefieldBoston$213K
- Osamu SakaiBoston$84K
- Alexander NorbashBoston$77K
- Varun NaragumSpringfield$75K
- Emanuele Orru'Burlington$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.